XOM Stock Analysis: Exxon Mobil | NYSE
Oil & Gas Integrated | NYSE, USA | Market Cap: 652.190m USD | 12M Return: 57.5% | US30233Q1085 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.20B
EPS Trend: -82.4%
Qual. Beats: -1
Rev. Trend: -10.7%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Exxon Mobil Corporation (NYSE: XOM) is an integrated oil and gas company headquartered in Spring, Texas, founded in 1870. The company operates through four segments: Upstream (exploration and production of crude oil and natural gas in the U.S., Canada, and internationally), Energy Products (fuels, aromatics, catalysts, and licensing services), Chemical Products (olefins, polyolefins, and intermediates), and Specialty Products (lubricants, basestocks, waxes, synthetics, elastomers, and resins). Beyond its core operations, Exxon Mobil is also involved in the manufacture, trade, transport, and sale of crude oil, natural gas, petroleum products, and petrochemicals, and sells its products under the Exxon, Esso, and Mobil brands.
The company is also pursuing lower-emission and emerging business opportunities, including carbon capture and storage (CCS), hydrogen, lower-emission fuels, its Proxxima resin systems, carbon materials, low-carbon data center solutions, and lithium, and it supplies aviation fuel. As a mega-cap member of the Integrated Oil & Gas sub-industry, Exxon Mobil participates across nearly the entire hydrocarbon value chain, from upstream extraction through midstream logistics, downstream refining and chemicals, and increasingly into energy transition technologies that have become a focal area for major oil majors as they adapt to evolving energy markets.
- Brent crude prices rally on tight supply outlook
- Refining margins widen on resilient product demand
- Permian and Guyana production growth drives upstream volumes
| Net Income: 32.8b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.07 > 1.0 |
| NWC/Revenue: 3.31% < 20% (prev 5.15%; Δ -1.83% < -1%) |
| CFO/TA 0.13 > 3% & CFO 59.7b > Net Income 32.8b |
| Net Debt (38.1b) to EBITDA (71.8b): 0.53 < 3 |
| Current Ratio: 1.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.17b) vs 12m ago -3.63% < -2% |
| Gross Margin: 25.15% > 18% (prev 22.49%; Δ 2.66% > 0.5%) |
| Asset Turnover: 79.17% > 50% (prev 73.59%; Δ 5.58% > 0%) |
| Interest Coverage Ratio: 64.98 > 6 (EBIT TTM 42.2b / Interest Expense TTM 649.0m) |
| A: 0.03 (Total Current Assets 101b - Total Current Liabilities 88.8b) / Total Assets 464b |
| B: 1.06 (Retained Earnings 493b / Total Assets 464b) |
| C: 0.09 (EBIT TTM 42.2b / Avg Total Assets 456b) |
| D: 1.31 (Book Value of Equity 259b / Total Liabilities 198b) |
| Altman-Z'' = 5.62 = AAA |
| DSRI: 1.32 (Receivables 60.6b/41.8b, Revenue 361b/329b) |
| GMI: 0.89 (GM 22.49% / 25.15%) |
| AQI: 0.97 (AQ_t 0.15 / AQ_t-1 0.15) |
| SGI: 1.10 (Revenue 361b / 329b) |
| TATA: -0.06 (NI 32.8b - CFO 59.7b) / TA 464b) |
| Beneish M = -2.81 (Cap -4..+1) = A |
As of August 21, 2026, the stock is trading at USD 166.15 with a total of 13,794,558 shares traded. Over the past week, the price has changed by +5.43%, over one month by +12.72%, over three months by +7.00% and over the past year by +57.53%.
Current recommended Stop Loss: 160.80 (which is 3.2% or 1.5 ATR below the current price).
Exxon Mobil has received a consensus analysts rating of 3.93. Therefore, it is recommended to buy XOM.
- StrongBuy: 10
- Buy: 7
- Hold: 10
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 168.8 | 1.6% |
P/E Trailing = 20.572
P/E Forward = 13.3869
P/S = 1.8063
P/B = 2.5331
P/EG = 1.2507
Revenue TTM = 361b USD
EBIT TTM = 42.2b USD
EBITDA TTM = 71.8b USD
Long Term Debt = 32.2b USD (from longTermDebt, last quarter)
Short Term Debt = 10.1b USD (from shortTermDebt, last quarter)
Debt = 48.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 6.31b
Net Debt = 38.1b USD (calculated: Debt 48.7b - CCE 10.6b)
Enterprise Value = 690b USD (652b + Debt 48.7b - CCE 10.6b)
Interest Coverage Ratio = 64.98 (Ebit TTM 42.2b / Interest Expense TTM 649.0m)
EV/FCF = 22.59x (Enterprise Value 690b / FCF TTM 30.6b)
FCF Yield = 4.43% (FCF TTM 30.6b / Enterprise Value 690b)
FCF Margin = 8.46% (FCF TTM 30.6b / Revenue TTM 361b)
Net Margin = 9.07% (Net Income TTM 32.8b / Revenue TTM 361b)
Gross Margin = 25.15% ((Revenue TTM 361b - Cost of Revenue TTM 270b) / Revenue TTM)
Gross Margin QoQ = 22.38% (prev 37.71%)
Tobins Q-Ratio = 1.49 (Enterprise Value 690b / Total Assets 464b)
Interest Expense / Debt = 1.33% (Interest Expense 649.0m / Debt 48.7b)
Taxrate = 25.63% (11.6b / 45.4b)
NOPAT = 31.4b (EBIT 42.2b * (1 - 25.63%))
Current Ratio = 1.13 (Total Current Assets 101b / Total Current Liabilities 88.8b)
Debt / Equity = 0.19 (Debt 48.7b / totalStockholderEquity, last quarter 259b)
Debt / EBITDA = 0.53 (Net Debt 38.1b / EBITDA 71.8b)
Debt / FCF = 1.25 (Net Debt 38.1b / FCF TTM 30.6b)
Total Stockholder Equity = 258b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.18% (Net Income 32.8b / Total Assets 464b)
RoE = 12.68% (Net Income TTM 32.8b / Total Stockholder Equity 258b)
RoCE = 14.51% (EBIT 42.2b / Capital Employed (Equity 258b + L.T.Debt 32.2b))
RoIC = 8.36% (NOPAT 31.4b / Invested Capital 375b)
WACC = 5.66% (E(652b)/V(701b) * Re(6.01%) + D(48.7b)/V(701b) * Rd(1.33%) * (1-Tc(0.26)))
Discount Rate = 6.01% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -12.12 | Cagr: 1.93%
[DCF] Terminal Value 76.07% ; FCFF base≈30.0b ; Y1≈31.3b ; Y5≈36.0b
[DCF] Fair Price = 125.6 (EV 555b - Net Debt 38.1b = Equity 516b / Shares 4.11b; r=8.35% [WACC [floored]]; 5y FCF grow 4.91% → 2.50% )
EPS Correlation: -82.38 | EPS CAGR: -12.62% | SUE: -3.20 | # QB: -1
Revenue Correlation: -10.72 | Revenue CAGR: -0.37% | SUE: 3.65 | # QB: 1
EPS current Quarter (2026-09-30): EPS=3.56 | Chg30d=+8.87% | Revisions=+35% | Analysts=17
EPS current Year (2026-12-31): EPS=11.58 | Chg30d=+5.32% | Revisions=+29% | GrowthEPS=+65.6% | GrowthRev=+21.3%
EPS next Year (2027-12-31): EPS=10.73 | Chg30d=+2.11% | Revisions=+0% | GrowthEPS=-7.3% | GrowthRev=-2.3%
[Analyst] Revisions Ratio: +22% (up=32, down=20)